News

Now in its 8th year, the conference and exhibition is the largest drug discovery meeting in the UK, and is expected to attract over 1000 delegates.

Select Biosciences South East Asia is pleased to report on the success of the inaugural International Bioprinting Congress, which took place at the Biopolis, Singapore on the 24-25 July 2014.

The promise of epigenetic research is its potential to identify additional sources of inter individual variability in drug disposition and response.

AstraZeneca agrees an initial consideration of $875 million on completion, which may rise to $1.22 billion in development, launch, and sales-related milestones.

Company will expand its Shanghai cGMP chemistry and microbiology laboratories to 2000m2 by Q2 2015.

Partnership will support pharmaceutical and biotech drug developers during the pre-clinical and formulation development stage.

Prototypes of the product are expected to begin shipping to early access partners by the end of this year.

Researchers at Yale School of Medicine have pinpointed a mechanism in part of the brain that is key to sensing glucose levels in the blood, linking it to both type 1 and type 2 diabetes.

By studying the injuries and aptitudes of Vietnam War veterans who suffered penetrating head wounds during the war, scientists are tackling- and beginning to answer- longstanding questions about how the brain works.

Scientists unravel a neural circuit that could play an important role in autism The insular cortex is an integral "hub," combining sensory, emotional and cognitive content. Not surprisingly, alterations in insular structure and function have been reported in many psychiatric disorders, such as anxiety disorders, depression, addiction and autism spectrum disorders (ASD).